Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Test Kit Detects Dengue Antibodies in Saliva

By LabMedica International staff writers
Posted on 09 Feb 2015
A paper-based disposable device has been developed that will allow dengue-specific antibodies to be detected easily from saliva within 20 minutes and the device is currently undergoing further development.

Paper-based immunoassays, usually in the form of lateral flow tests, are currently the standard platform for home diagnostics. More...
However, conventional lateral tests are often complicated by severe nonspecific adsorption of detector particles when applied to test samples containing salivary fluid.

Scientists at the Institute of Bioengineering and Nanotechnology (The Nanos; Singapore) developed a stacking flow device consisting of a test strip, a sample pad, a reagent pad, an absorbent pad, and a flow regulator. The sample and reagent pads were made of glass fiber, and the absorbent pad was made of cellulose (Merck Millipore, Billerica, Massachusetts, USA). The nitrocellulose test strip was cut into the required dimensions manually with a roller cutter. The detection of dengue-specific immunoglobulin G (IgG) was conducted using the liquid conjugate approach. The liquid conjugate was composed of protein G-conjugated 40 nm gold nanoparticles.

In the device, different flow paths are created for samples and reagents through a multiple stacked system. This allows the saliva sample to flow separately through a fiber glass matrix, which removes the substances that would interfere with the nanoparticle-based sensing system before it mixes with the sensor nanoparticles. The device’s configuration also helps to regulate the flow in the test strip, generating uniform test lines for more accurate results. The stacking flow immunoassay platform requires only one user activation step: both the sample and reagents are added at the same time in a single step. Both the sample and reagents react and flow concurrently in the test strip. The single-step procedure significantly improved the ease of usage of the test kit. The study was published on January 12, 2015, in the journal Lab on a Chip.

Related Links:

Institute of Bioengineering and Nanotechnology
Merck Millipore  



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Aspiration System
VACUSAFE
New
Hematology Consumables
Bioblood Devices
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.